ArticleACS medicinal chemistry letters2018

Discovery and in Vitro Optimization of 3-Sulfamoylbenzamides as ROMK Inhibitors.

Matthew F Sammons et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.